Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Hum Mutat. 2011 Nov 3;33(1):8–21. doi: 10.1002/humu.21627

Table 3. Proposed classification for DNA sequence variants and correlation of clinical recommendation with probability that any given alteration is deleterious.

Class Definition Posterior Probability Clinical Testing Surveillance recommendations
5 Definitely pathogenic >0.99 Test at-risk relatives for the variant Full high-risk surveillance
4 Likely pathogenic 0.95-0.99 Test at-risk relatives for the variant Full high-risk surveillance
3 Uncertain 0.05-0.949 Do not use as predictive testing in at-risk relatives Counsel based on family history and other risk factors
2 Likely not pathogenic 0.001-0.049 Do not use as predictive testing in at-risk relatives Counsel as if no mutation detected
1 Not Pathogenic <0.001 Do not use as predictive testing in at-risk relatives Counsel as if no mutation detected

Adapted from Plon et al., 2008.